Valbiotis: Funding, Investors & Team (Aug 2026)
In response to unmet medical requirements, Valbiotis is a research and development organization dedicated to using scientific innovation to prevent and treat metabolic and cardiovascular disorders. By creating a new class of health nutrition products with a multi-target strategy made possible by the utilization of plant-based terrestrial and marine resources, Valbiotis has taken a novel approach to lowering the risk of serious metabolic and cardiovascular disorders. The Company, which was founded in La Rochelle at the beginning of 2014, has three locations in France: Périgny, La Rochelle (17), and Riom (63), as well as a subsidiary in Quebec City (Canada)
Valbiotis has raised $9.7M across 1 funding round on record, the most recent an undisclosed round of $9.7M announced in Nov 2022.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Valbiotis Company Profile and Key Stats
Latest funding round on record: Nov 2022.
Valbiotis Funding Rounds
Valbiotis Founders and Leadership Team
Contact details for the Valbiotis team: 1 of 1 has an email address on file.
Start 14-day free trial →Valbiotis Funding Compared to Other Biotechnology Startups
Valbiotis' latest round of $9.7M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Valbiotis in Biotechnology and La Rochelle
Companies Similar to Valbiotis
Brenus Pharma is a platform that uses allogeneic techniques to create immune therapy with the goal of…
TISSIUM is a privately owned medical device company based in Paris, France that is dedicated to the rapid…
NicOx is a biopharmaceutical company that focuses on creating and selling nitric oxide-donating drugs for…
Advicenne is a specialty pharmaceutical company dedicated to improving the lives of patients who suffer from…
One Biosciences was founded in Paris, Ile-de-France, France by Magali Richard, David Schilansky, and Céline…
Inventiva Pharma is a biopharmaceutical company in the clinical stage that focuses on creating oral small…
NETRIS Pharma develops therapeutic molecules for treating cancer by targeting dependence receptors for the…
AbIONYX Pharma is a biotechnology company that is focused on providing innovative therapies for indications…
Founded in 2003, Nanobiotix is at the forefront of nanomedicine and is committed to revolutionizing patient…
Theraclion specializes in high-tech medical equipment using high-intensity focused ultrasound (HIFU). They…
Abivax, a clinical stage biotechnology company, is mobilizing the body’s natural immune machinery to treat…
AB Science was established in 2001 by a group of individuals in the medical and business fields who are…
Valbiotis Funding FAQs
What does Valbiotis do?
In response to unmet medical requirements, Valbiotis is a research and development organization dedicated to using scientific innovation to prevent and treat metabolic and cardiovascular disorders. By creating a new class of health nutrition products with a multi-target strategy made possible by the utilization of plant-based terrestrial and marine resources, Valbiotis has taken a novel approach to lowering the risk of serious metabolic and cardiovascular disorders. The Company, which was founded in La Rochelle at the beginning of 2014, has three locations in France: Périgny, La Rochelle (17), and Riom (63), as well as a subsidiary in Quebec City (Canada)
How much funding has Valbiotis raised?
Valbiotis has raised $9.7M across 1 round on record. The most recent is an undisclosed round of $9.7M announced in Nov 2022.
When did Valbiotis last raise funding?
Valbiotis' most recent funding round on record is an undisclosed round of $9.7M, announced in Nov 2022.
Who is the CEO of Valbiotis?
Sebastien Peltier is listed as CEO at Valbiotis.
Where is Valbiotis headquartered?
Valbiotis is based in La Rochelle, Poitou-Charentes, France.
How many employees does Valbiotis have?
Valbiotis is in the 11-50 employee band.
How does Valbiotis' funding compare to other Biotechnology startups?
Valbiotis' latest round of $9.7M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Valbiotis Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Valbiotis is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.